乙肝病毒感染患者谷胱甘肽还原酶水平特点及与肝纤维化的关系

doi:10.3969/j.issn.1001-8131.2025.04.017

Abstract
Figure/Table
References
Related Citation (15)

[1] NILSSON S S,DEMANT J,THONNINGS S,et al.Dried blood spot:A diagnostic detection method for HBV,HCV and HIV nucleic acid using a single drop of blood[J].Diagn Microbiol Infect Dis,2025,111(3):116661.
[2] GIANNAKOPOULOU E,PARDALI V,EDWARDS T C,et al.Identification and assessment of the 1,6-dihydroxy-pyridin-2-one moiety as privileged scaffold for HBV ribonuclease H inhibition[J].Antiviral Res,2024,223:105833.
[3] 何伟,田水林,施卫兵.不同年龄段慢性乙型肝炎患者乙肝相关指标与肝纤维化的相关性研究[J].中国医刊,2023,58(12):1307-1312.
[4] 梁甜,周琳,周晓玲.NLRP3炎症小体介导的肝纤维化炎症反应及激活机制研究进展[J].临床与实验病理学杂志,2024,40(6):636-639.
[5] 黎灵锋,刘桂荣,谢燕芳,等.血清谷胱甘肽还原酶在HBV相关性肝病中的应用研究[J].标记免疫分析与临床,2023,30(2):304-308.
[6] 沈婷婷,朱哿瑞,王帆,等.基因表达谱分析非酒精性脂肪性肝病中谷胱甘肽转移酶的作用[J].临床肝胆病杂志,2023,39(1):89-96.
[7] 庄辉. 慢性乙型肝炎防治指南(2022年版)修订过程中关于慢性HBV感染自然史的讨论[J].临床肝胆病杂志,2023,39(6):1295-1298.
[8] 王雅倩. 肝脏纤维化程度的超声评估及对纤维化程度的分级价值研究[J].临床合理用药杂志,2017,10(14):2.
[9] GAO Y,ZHANG S,ZHANG X,et al.Effect and Mechanism of microRNA in Exocrine Secreted by Hepatitis B In-fected Hepatocytes on Activation of Hepatic Stellate Cells and Hepatic Fibrosis[J].Indian Journal of Pharma-ceutical Sciences,2024,86(2).
[10] 林佩娜,龚隽逸,刘肖瑛,等.谷胱甘肽还原酶联合检测在乙型肝炎中的应用[J].实用检验医师杂志,2021,13(2):4.
[11] 王佳,高峰,严士海,等.CHB合并EBV感染患者外周血双阴性T淋巴细胞和滤泡辅助性T细胞水平及其临床意义[J].分子诊断与治疗杂志,2024,16(10):1914-1917.
[12] Zhao Z F,Qin S,Wang L,et al.Correlation between gut microbiota and liver biochemical indicators in patients with chronic hepatitis B.Chinese Journal of Biotechno-logy,2021,37(1):301-311.
[13] 吴娜,苏汝开,张建秋,等.富马酸替诺福韦二吡呋酯对慢性重型乙型肝炎患者的免疫及炎性反应影响[J].疑难病杂志,2023,22(12):1302-1306.
[14] 刘贞. 血清谷胱甘肽还原酶在慢性肝炎中的辅助诊断价值[J].中国医药科学,2021,11(19):4.
[15] Aleknaviiūt-Valien G,Banys V.Clinical importance of laboratory biomarkers in liver fibrosis.Biochem Med(Zagreb).2022;32(3):030501.doi:10.11613/BM.2022.030501
[16] Gzceliolu B,Uras S,entürk M,et al.Exploring the enzyme inhibitory properties of Antarctic algal extracts[J].Turkish Journal of Biochemistry,2023,48(5):592-602.
[17] HOU XL,WANG YB,LU W,et al.Value of five noni-nvasive serum models in the diagnosis of chronic hepati-tis B liver fibrosis[J].J Clin Hepatol,2021,37(7):1567-1571.
[18] 李聪颖,杨占江,杜广清.还原型谷胱甘肽联合多烯磷脂酰胆碱对急性药物性肝损害患者CRP IL-6 PCT及肝功能的影响[J].河北医学,2021,27(7):1076-1081.
[19] 万蒙,杨杨.Graves病合并自身免疫性肝病一例[J].临床内科杂志,2021,38(9):637-638.
[20] 胡利琳,王玮珺,杨玲.肝细胞型胆汁淤积诊治进展[J].实用肝脏病杂志,2020,23(1):5.
[21] 陈秀梅,王英杰,赵成周,等.三味甘露对大鼠肝纤维化的改善作用及机制[J].中国药房,2024,35(6):707-711.